Study S000145

Evaluating the Efficacy of Various Weekly GLP1receptor Agonist Among Obese Individuals Without Diabetes

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record Study Protocol, Statistical Analysis Plan, and Informed Consent Form (PDF)

Registration

Registration: NCT07834398
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE3
Masking: NONE
Status: COMPLETED
Enrollment: 150
Start: 2025-11-14
Primary completion: 2026-04-13
Lead sponsor: Zagazig University
Conditions: Non-diabetec Obesity; Obesity (Disorder)
Interventions: DRUG:Dulaglutide; DRUG:Semagludtide; DRUG:Tirzepatide
Results posted: FALSE
Individual participant data sharing: YES

Registered primary outcomes

change in body weight at 3 and 6 months [Baseline, Week 12 (3 months) and Week 24 (6 months)]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.